NUVB vs. CMPS
NUVB (Nuvation Bio Inc.) and CMPS (COMPASS Pathways plc) are both stocks. Both are in the Healthcare sector — NUVB in Biotechnology, CMPS in Medical Care Facilities. Over the past 5 years, NUVB returned -15.85%/yr vs -17.04%/yr for CMPS. At a 0.28 correlation, their price movements are largely independent.
Performance
NUVB vs. CMPS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NUVB achieves a -42.30% return, which is significantly lower than CMPS's 89.13% return.
NUVB
- 1D
- 9.53%
- 1M
- 7.04%
- YTD
- -42.30%
- 6M
- -37.79%
- 1Y
- 111.02%
- 3Y*
- 45.17%
- 5Y*
- -15.85%
- 10Y*
- —
CMPS
- 1D
- 2.84%
- 1M
- 40.02%
- YTD
- 89.13%
- 6M
- 129.75%
- 1Y
- 188.72%
- 3Y*
- 20.38%
- 5Y*
- -17.04%
- 10Y*
- —
NUVB vs. CMPS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
NUVB Nuvation Bio Inc. | -42.30% | 236.84% | 76.16% | -21.35% | -77.41% | -27.35% | 6.36% |
CMPS COMPASS Pathways plc | 89.13% | 82.54% | -56.80% | 8.97% | -63.67% | -53.61% | 64.28% |
Correlation
The correlation between NUVB and CMPS is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Sep 21, 2020 | 0.28 |
Fundamentals
NUVB:
$1.95B
CMPS:
$1.70B
NUVB:
-$0.42
CMPS:
-$1.73
NUVB:
6.11
CMPS:
5.20
NUVB:
$143.05M
CMPS:
$0.00
NUVB:
$131.08M
CMPS:
$0.00
NUVB:
-$139.03M
CMPS:
-$312.16M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NUVB vs. CMPS — Risk / Return Rank
NUVB
CMPS
NUVB vs. CMPS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nuvation Bio Inc. (NUVB) and COMPASS Pathways plc (CMPS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NUVB | CMPS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.62 | ||
| Sortino ratioReturn per unit of downside risk | -0.36 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.38 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 1.94 | 3.72 | -1.78 |
| Martin ratioReturn relative to average drawdown | 3.54 | 11.24 | -7.70 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NUVB | CMPS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.22 | 1.84 | -0.62 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.21 | -0.21 | 0.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.15 | -0.16 | +0.01 |
Drawdowns
NUVB vs. CMPS - Drawdown Comparison
The maximum NUVB drawdown since its inception was -93.39%, roughly equal to the maximum CMPS drawdown of -96.03%. Use the drawdown chart below to compare losses from any high point for NUVB and CMPS.
Loading charts...
Drawdown Indicators
| NUVB | CMPS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.39% | -96.03% | +2.64% |
Max Drawdown (1Y)Largest decline over 1 year | -57.55% | -51.04% | -6.51% |
Max Drawdown (3Y)Largest decline over 3 years | -58.19% | -81.00% | +22.81% |
Max Drawdown (5Y)Largest decline over 5 years | -92.88% | -95.20% | +2.32% |
Current DrawdownCurrent decline from peak | -64.52% | -77.96% | +13.44% |
Average DrawdownAverage peak-to-trough decline | -65.50% | -74.12% | +8.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.46% | 16.86% | +14.60% |
Volatility
NUVB vs. CMPS - Volatility Comparison
The current volatility for Nuvation Bio Inc. (NUVB) is 18.34%, while COMPASS Pathways plc (CMPS) has a volatility of 26.38%. This indicates that NUVB experiences smaller price fluctuations and is considered to be less risky than CMPS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NUVB | CMPS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.34% | 26.38% | -8.04% |
Volatility (6M)Calculated over the trailing 6-month period | 53.53% | 68.37% | -14.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 91.74% | 103.15% | -11.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 75.58% | 79.95% | -4.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 73.11% | 81.78% | -8.67% |
Dividends
NUVB vs. CMPS - Dividend Comparison
Neither NUVB nor CMPS has paid dividends to shareholders.
Financials
NUVB vs. CMPS - Financials Comparison
This section allows you to compare key financial metrics between Nuvation Bio Inc. and COMPASS Pathways plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NUVB and CMPS have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CMPS has higher volatility (26.38%) compared to NUVB (18.34%). In terms of maximum drawdown, NUVB dropped -93.39% vs CMPS's -96.03%.
CMPS currently has the higher Sharpe Ratio (1.84 vs 1.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NUVB and CMPS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer